Search

everythinglearnresearchcommunity

for

Search:↓

Extracts from Tridax procumbens L. have strong anti-inflammatory and antioxidant effects and block inflammation-causing enzymes.

Applying a specific inhibitor lightens skin and hair color.

Trps1 is essential for proper hair follicle development.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Gefitinib can cause hair loss without scarring.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Apremilast may help treat hair loss in alopecia areata.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

Entospletinib effectively prevents eye and skin GVHD in mice.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Allopregnanolone helps control oxytocin levels during pregnancy to prevent preterm labor.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Erlotinib can cause persistent excessive hair growth.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

EGFR inhibitors often cause skin issues like acne and dryness, which can be managed with specific treatments.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.